Bora Pharmaceuticals USA Inc. announced that it will receive $57,000,000 in an equity round of funding on May 14, 2024. The transaction include the participation from returning investor, Bora Pharmaceuticals Co., LTD., hold 100% stake in the company. The transaction has been approved by the board of directors of the company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
764 TWD | +4.66% | +1.60% | +19.56% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.56% | 2.37B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- 6472 Stock
- News Bora Pharmaceuticals Co., LTD.
- Bora Pharmaceuticals USA Inc. announced that it expects to receive $57 million in funding from Bora Pharmaceuticals Co., LTD.